PDB Short entry for 2NSD HEADER OXIDOREDUCTASE 03-NOV-06 2NSD TITLE ENOYL ACYL CARRIER PROTEIN REDUCTASE INHA IN COMPLEX WITH N-(4- TITLE 2 METHYLBENZOYL)-4-BENZYLPIPERIDINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NADH-DEPENDENT ENOYL-ACP REDUCTASE; COMPND 5 EC: 1.3.1.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS H37RV; SOURCE 3 ORGANISM_TAXID: 83332; SOURCE 4 STRAIN: H37RV; SOURCE 5 GENE: INHA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 GOLD (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS OXIDOREDUCTASE, INHA, ENOYL ACYL CARRIER REDUCTASE, N-(4- KEYWDS 2 METHYLBENZOYL)-4-BENZYLPIPERIDINE EXPDTA X-RAY DIFFRACTION AUTHOR X.HE,A.ALIAN,P.R.ORTIZ DE MONTELLANO REVDAT 4 30-AUG-23 2NSD 1 REMARK REVDAT 3 24-FEB-09 2NSD 1 VERSN REVDAT 2 16-OCT-07 2NSD 1 JRNL REVDAT 1 18-SEP-07 2NSD 0 JRNL AUTH X.HE,A.ALIAN,P.R.ORTIZ DE MONTELLANO JRNL TITL INHIBITION OF THE MYCOBACTERIUM TUBERCULOSIS ENOYL ACYL JRNL TITL 2 CARRIER PROTEIN REDUCTASE INHA BY ARYLAMIDES. JRNL REF BIOORG.MED.CHEM. V. 15 6649 2007 JRNL REFN ISSN 0968-0896 JRNL PMID 17723305 JRNL DOI 10.1016/J.BMC.2007.08.013 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.9 REMARK 3 NUMBER OF REFLECTIONS : 55379 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.236 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 4243 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3610 REMARK 3 BIN FREE R VALUE : 0.3810 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 597 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3992 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 132 REMARK 3 SOLVENT ATOMS : 310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.53000 REMARK 3 B22 (A**2) : 5.51000 REMARK 3 B33 (A**2) : -10.04000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.35 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.37 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.700 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.020 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2NSD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-NOV-06. REMARK 100 THE DEPOSITION ID IS D_1000040244. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-MAR-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.11590 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60907 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 41.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.9 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : 0.05000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 24.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.69600 REMARK 200 R SYM FOR SHELL (I) : 0.69600 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1P45 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8% MPD, 50MM SODIUM CITRATE PH 6.5, REMARK 280 100MM HEPES PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y,-Z REMARK 290 8555 X,-Y,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 45.63150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 92.12950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.66350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 92.12950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 45.63150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.66350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 45.63150 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 45.66350 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 92.12950 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 45.66350 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 45.63150 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 92.12950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 421 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 462 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 555 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 551 O HOH A 552 2.01 REMARK 500 NH2 ARG A 173 O HOH A 503 2.12 REMARK 500 O LEU B 4 O HOH B 504 2.12 REMARK 500 O HOH A 550 O HOH A 551 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O GLU B 80 O HOH B 535 6765 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 16 -30.14 -132.95 REMARK 500 ASP A 42 -91.78 70.58 REMARK 500 VAL A 65 -3.49 -59.84 REMARK 500 PHE A 97 146.45 -170.85 REMARK 500 ASP A 150 106.38 -35.60 REMARK 500 ALA A 157 -49.54 66.13 REMARK 500 ASN A 159 -114.28 35.59 REMARK 500 LEU A 207 -29.74 -154.64 REMARK 500 GLU A 210 -73.21 -71.73 REMARK 500 SER A 247 -169.91 -78.58 REMARK 500 ALA A 260 79.44 -110.91 REMARK 500 ASP A 261 24.53 -142.35 REMARK 500 ILE B 16 -30.91 -136.77 REMARK 500 PHE B 41 -86.03 -93.48 REMARK 500 PHE B 97 143.00 -174.81 REMARK 500 ALA B 124 -57.69 -120.57 REMARK 500 ASP B 150 108.22 -38.28 REMARK 500 ALA B 157 -48.98 69.65 REMARK 500 ASN B 159 -113.80 36.46 REMARK 500 LEU B 207 -110.66 53.59 REMARK 500 ALA B 260 77.52 -112.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4PI A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4PI B 400 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2H7I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS ENOYL REDUCTASE REMARK 900 (INHA) COMPLEXED WITH 1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3- REMARK 900 CARBOXAMIDE REMARK 900 RELATED ID: 2H7L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS ENOYL REDUCTASE REMARK 900 (INHA) COMPLEXED WITH N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5- REMARK 900 OXOPYRROLIDINE-3-CARBOXAMIDE REMARK 900 RELATED ID: 2H7M RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS ENOYL REDUCTASE REMARK 900 (INHA) COMPLEXED WITH 1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5- REMARK 900 OXOPYRROLIDINE-3-CARBOXAMIDE REMARK 900 RELATED ID: 2H7N RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS ENOYL REDUCTASE REMARK 900 (INHA) COMPLEXED WITH N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5- REMARK 900 OXOPYRROLIDINE-3-CARBOXAMIDE REMARK 900 RELATED ID: 2H7P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS ENOYL REDUCTASE REMARK 900 (INHA) COMPLEXED WITH N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5- REMARK 900 OXOPYRROLIDINE-3-CARBOXAMIDE REMARK 900 RELATED ID: 1P45 RELATED DB: PDB REMARK 900 SIMILAR PROTEIN DBREF 2NSD A 1 269 UNP P0A5Y6 INHA_MYCTU 1 269 DBREF 2NSD B 1 269 UNP P0A5Y6 INHA_MYCTU 1 269 SEQRES 1 A 269 MET THR GLY LEU LEU ASP GLY LYS ARG ILE LEU VAL SER SEQRES 2 A 269 GLY ILE ILE THR ASP SER SER ILE ALA PHE HIS ILE ALA SEQRES 3 A 269 ARG VAL ALA GLN GLU GLN GLY ALA GLN LEU VAL LEU THR SEQRES 4 A 269 GLY PHE ASP ARG LEU ARG LEU ILE GLN ARG ILE THR ASP SEQRES 5 A 269 ARG LEU PRO ALA LYS ALA PRO LEU LEU GLU LEU ASP VAL SEQRES 6 A 269 GLN ASN GLU GLU HIS LEU ALA SER LEU ALA GLY ARG VAL SEQRES 7 A 269 THR GLU ALA ILE GLY ALA GLY ASN LYS LEU ASP GLY VAL SEQRES 8 A 269 VAL HIS SER ILE GLY PHE MET PRO GLN THR GLY MET GLY SEQRES 9 A 269 ILE ASN PRO PHE PHE ASP ALA PRO TYR ALA ASP VAL SER SEQRES 10 A 269 LYS GLY ILE HIS ILE SER ALA TYR SER TYR ALA SER MET SEQRES 11 A 269 ALA LYS ALA LEU LEU PRO ILE MET ASN PRO GLY GLY SER SEQRES 12 A 269 ILE VAL GLY MET ASP PHE ASP PRO SER ARG ALA MET PRO SEQRES 13 A 269 ALA TYR ASN TRP MET THR VAL ALA LYS SER ALA LEU GLU SEQRES 14 A 269 SER VAL ASN ARG PHE VAL ALA ARG GLU ALA GLY LYS TYR SEQRES 15 A 269 GLY VAL ARG SER ASN LEU VAL ALA ALA GLY PRO ILE ARG SEQRES 16 A 269 THR LEU ALA MET SER ALA ILE VAL GLY GLY ALA LEU GLY SEQRES 17 A 269 GLU GLU ALA GLY ALA GLN ILE GLN LEU LEU GLU GLU GLY SEQRES 18 A 269 TRP ASP GLN ARG ALA PRO ILE GLY TRP ASN MET LYS ASP SEQRES 19 A 269 ALA THR PRO VAL ALA LYS THR VAL CYS ALA LEU LEU SER SEQRES 20 A 269 ASP TRP LEU PRO ALA THR THR GLY ASP ILE ILE TYR ALA SEQRES 21 A 269 ASP GLY GLY ALA HIS THR GLN LEU LEU SEQRES 1 B 269 MET THR GLY LEU LEU ASP GLY LYS ARG ILE LEU VAL SER SEQRES 2 B 269 GLY ILE ILE THR ASP SER SER ILE ALA PHE HIS ILE ALA SEQRES 3 B 269 ARG VAL ALA GLN GLU GLN GLY ALA GLN LEU VAL LEU THR SEQRES 4 B 269 GLY PHE ASP ARG LEU ARG LEU ILE GLN ARG ILE THR ASP SEQRES 5 B 269 ARG LEU PRO ALA LYS ALA PRO LEU LEU GLU LEU ASP VAL SEQRES 6 B 269 GLN ASN GLU GLU HIS LEU ALA SER LEU ALA GLY ARG VAL SEQRES 7 B 269 THR GLU ALA ILE GLY ALA GLY ASN LYS LEU ASP GLY VAL SEQRES 8 B 269 VAL HIS SER ILE GLY PHE MET PRO GLN THR GLY MET GLY SEQRES 9 B 269 ILE ASN PRO PHE PHE ASP ALA PRO TYR ALA ASP VAL SER SEQRES 10 B 269 LYS GLY ILE HIS ILE SER ALA TYR SER TYR ALA SER MET SEQRES 11 B 269 ALA LYS ALA LEU LEU PRO ILE MET ASN PRO GLY GLY SER SEQRES 12 B 269 ILE VAL GLY MET ASP PHE ASP PRO SER ARG ALA MET PRO SEQRES 13 B 269 ALA TYR ASN TRP MET THR VAL ALA LYS SER ALA LEU GLU SEQRES 14 B 269 SER VAL ASN ARG PHE VAL ALA ARG GLU ALA GLY LYS TYR SEQRES 15 B 269 GLY VAL ARG SER ASN LEU VAL ALA ALA GLY PRO ILE ARG SEQRES 16 B 269 THR LEU ALA MET SER ALA ILE VAL GLY GLY ALA LEU GLY SEQRES 17 B 269 GLU GLU ALA GLY ALA GLN ILE GLN LEU LEU GLU GLU GLY SEQRES 18 B 269 TRP ASP GLN ARG ALA PRO ILE GLY TRP ASN MET LYS ASP SEQRES 19 B 269 ALA THR PRO VAL ALA LYS THR VAL CYS ALA LEU LEU SER SEQRES 20 B 269 ASP TRP LEU PRO ALA THR THR GLY ASP ILE ILE TYR ALA SEQRES 21 B 269 ASP GLY GLY ALA HIS THR GLN LEU LEU HET NAD A 300 44 HET 4PI A 400 22 HET NAD B 300 44 HET 4PI B 400 22 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 4PI N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE HETSYN 4PI (4-BENZYLPIPERIDIN-1-YL)(P-TOLYL)METHANONE FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 4 4PI 2(C20 H23 N O) FORMUL 7 HOH *310(H2 O) HELIX 1 1 SER A 20 GLN A 32 1 13 HELIX 2 2 ARG A 43 ASP A 52 1 10 HELIX 3 3 ASN A 67 GLY A 83 1 17 HELIX 4 4 PRO A 99 MET A 103 5 5 HELIX 5 5 PRO A 107 ALA A 111 5 5 HELIX 6 6 PRO A 112 ALA A 124 1 13 HELIX 7 7 ALA A 124 LEU A 135 1 12 HELIX 8 8 TYR A 158 LYS A 181 1 24 HELIX 9 9 THR A 196 ALA A 206 1 11 HELIX 10 10 ALA A 211 ALA A 226 1 16 HELIX 11 11 ALA A 235 SER A 247 1 13 HELIX 12 12 GLY A 263 GLN A 267 5 5 HELIX 13 13 SER B 20 GLN B 32 1 13 HELIX 14 14 ARG B 43 ASP B 52 1 10 HELIX 15 15 ASN B 67 GLY B 83 1 17 HELIX 16 16 PRO B 99 MET B 103 5 5 HELIX 17 17 PRO B 107 ALA B 111 5 5 HELIX 18 18 PRO B 112 ALA B 124 1 13 HELIX 19 19 ALA B 124 LEU B 135 1 12 HELIX 20 20 TYR B 158 LYS B 181 1 24 HELIX 21 21 THR B 196 GLY B 204 1 9 HELIX 22 22 ALA B 211 ALA B 226 1 16 HELIX 23 23 ALA B 235 SER B 247 1 13 HELIX 24 24 GLY B 263 GLN B 267 5 5 SHEET 1 A 7 LEU A 60 GLU A 62 0 SHEET 2 A 7 ALA A 34 GLY A 40 1 N LEU A 38 O LEU A 61 SHEET 3 A 7 LYS A 8 SER A 13 1 N LYS A 8 O GLN A 35 SHEET 4 A 7 LEU A 88 HIS A 93 1 O ASP A 89 N ARG A 9 SHEET 5 A 7 MET A 138 ASP A 148 1 O VAL A 145 N HIS A 93 SHEET 6 A 7 ARG A 185 ALA A 191 1 O ARG A 185 N ILE A 144 SHEET 7 A 7 ASP A 256 ALA A 260 1 O ILE A 258 N LEU A 188 SHEET 1 B 7 LEU B 60 GLU B 62 0 SHEET 2 B 7 GLN B 35 GLY B 40 1 N LEU B 38 O LEU B 61 SHEET 3 B 7 ARG B 9 SER B 13 1 N VAL B 12 O VAL B 37 SHEET 4 B 7 LEU B 88 HIS B 93 1 O ASP B 89 N ARG B 9 SHEET 5 B 7 MET B 138 ASP B 148 1 O VAL B 145 N HIS B 93 SHEET 6 B 7 ARG B 185 ALA B 191 1 O VAL B 189 N ASP B 148 SHEET 7 B 7 ASP B 256 ALA B 260 1 O ILE B 258 N LEU B 188 SITE 1 AC1 31 GLY A 14 ILE A 15 ILE A 16 SER A 20 SITE 2 AC1 31 ILE A 21 PHE A 41 LEU A 63 ASP A 64 SITE 3 AC1 31 VAL A 65 SER A 94 ILE A 95 GLY A 96 SITE 4 AC1 31 ILE A 122 MET A 147 ASP A 148 PHE A 149 SITE 5 AC1 31 LYS A 165 ALA A 191 PRO A 193 ILE A 194 SITE 6 AC1 31 THR A 196 MET A 199 4PI A 400 HOH A 429 SITE 7 AC1 31 HOH A 439 HOH A 441 HOH A 442 HOH A 456 SITE 8 AC1 31 HOH A 537 HOH A 538 HOH A 554 SITE 1 AC2 29 GLY B 14 ILE B 16 SER B 20 ILE B 21 SITE 2 AC2 29 PHE B 41 LEU B 63 ASP B 64 VAL B 65 SITE 3 AC2 29 SER B 94 ILE B 95 GLY B 96 ILE B 122 SITE 4 AC2 29 MET B 147 ASP B 148 PHE B 149 LYS B 165 SITE 5 AC2 29 ALA B 191 PRO B 193 ILE B 194 THR B 196 SITE 6 AC2 29 MET B 199 4PI B 400 HOH B 445 HOH B 457 SITE 7 AC2 29 HOH B 460 HOH B 465 HOH B 472 HOH B 477 SITE 8 AC2 29 HOH B 513 SITE 1 AC3 9 GLY A 96 PHE A 149 TYR A 158 PRO A 193 SITE 2 AC3 9 MET A 199 LEU A 218 GLU A 219 TRP A 222 SITE 3 AC3 9 NAD A 300 SITE 1 AC4 8 GLY B 96 TYR B 158 PRO B 193 MET B 199 SITE 2 AC4 8 LEU B 218 GLU B 219 TRP B 222 NAD B 300 CRYST1 91.263 91.327 184.259 90.00 90.00 90.00 I 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010957 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010950 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005427 0.00000